黑料网官网

Worldwide some 14 million people will be diagnosed with cancer this year. Novonco is at the forefront of cancer research, working to help transform care from one-size-fits-all treatments to therapies that are personalized to the patient. In collaboration with leading scientists from City of Hope and the University of California, Irvine, Novonco is advancing precision medicine through the development of novel small molecules to treat a number of solid and hematologic cancers.